Reverse remodelling in heart failure with cardiac resynchronisation therapy.

Area of Science:

• Cardiology
• Heart Failure Research
• Medical Device Technology

Background:

• Systolic heart failure is characterized by progressive left ventricular (LV) remodelling, leading to poor prognosis.
• LV remodelling involves dilatation, reduced contractile function, and altered cavity shape, triggered by various factors.
• Current treatments focus on slowing or halting this detrimental remodelling process.

Purpose of the Study:

• To review the application of cardiac resynchronisation therapy (CRT) in managing chronic, severe, systolic heart failure.
• To explore the concept of "reverse remodelling" as a therapeutic goal in heart failure.
• To evaluate CRT's efficacy in achieving reverse remodelling and improving LV function.

Main Methods:

• Review of existing literature on cardiac resynchronisation therapy and heart failure.
• Analysis of studies investigating left ventricular remodelling in systolic heart failure.
• Examination of data correlating CRT with changes in LV structure and function.

Main Results:

• Cardiac resynchronisation therapy (CRT) is identified as a novel and effective treatment for systolic heart failure.
• CRT is associated with significant "reverse remodelling" of the left ventricle.
• This reverse remodelling involves partial reversal of LV dilatation and improved contractile function.

Conclusions:

• Cardiac resynchronisation therapy (CRT) offers a promising therapeutic approach for severe systolic heart failure.
• CRT facilitates reverse remodelling, counteracting the adverse effects of LV remodelling.
• The findings support CRT as a valuable intervention for improving outcomes in heart failure patients.